Age: 1.43
Sex: M
Vaccine: MMR, HIBV
Symptoms: Rash, Repetitive speech, Respiratory syncytial virus infection, Speech disorder
Clinical narrative: Information has been received regarding a case in litigation concerning a minor male pt who was exposed to high levels of mercury from thimerosal through exposure to unspecified products. The alleged result was that the pt experienced serious and permanent neurological injuries and damages which included past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments. It was also alleged that the pt experienced cumulative mercury toxicity. Information has been received from medical records concerning an approx 17 month old male child with developmental delay with minimal delay in gross motor and mild delay in fine motor and drug hypersensitivity to Suprax and amoxicillin (rash) with a history of hospitalization for bronchiolitis secondary to respiratory syncytial virus infection (RSV)  and unspecified reaction after vaccination with DPT. On 5/22/1990, the pt was vaccinated, in the right leg with a dose of MMR II (lot 1022S). On approx 5/22/1990 the pt developed an unspecified reaction to MMR II. ON an unspecified date the pt developed mental retardation. In approx 1989 the pt began to have temper tantrums. On approx 6/14/90, at age 2 and a half, the pt was diagnosed with pervasive developmental disorder. On 4/30/91, the pts mother reported possible speech regression. She reported that the pt was not speaking well and had previously spoken 4 to 5 words. On 6/5/91, tympanometry results revealed type B flat and was suggestive of conductive component. On 6/16/92, the pts mother reported that the pt was still not talking, however he imitated other people. ON 7/15/992, tympanogram results reported that the right ear was type A within normal limits and left ear was type B flat suggestive of a possible conductive component in the left ear. On 8/6/93 a developmental pediatric evaluation revealed the pts developmental function was at the 21-24 month level and he displayed behavior problems with noncompliance. In approx April 99, pt began to display new behavior problems such as, stealing, fighting and choking other kids. A behavior therapist was recommended. It was reported that in 1999, after his parents separated, the pt began to isolate himself and did not like to leave home. When taken into public he would engage in high frequency of flatulence. In approx 2002, the pt developed repetitive verbal behavior. The mother reported that the pt would reconstruct conversations that he heard taking on the identity of others. He would begin to name items such as a list of foods, without stopping. He would laugh with out obvious precipitant, He did not engage in any adaptive vocal verbal behavior. It was reported that outbursts, in the form of property destruction, gestures of physically aggression and negative vocalization began when he was in middle school. He has one or two outbursts per month and last for 20 to 30 minutes in duration. ON 1/21/03, the pt underwent a behavior psychology evaluation for behavioral outbursts, isolation and repetitive verbal behavior. On 5/16/05, the pt underwent another behavior psychology evaluation for tantrums. It was reported that the pt would yell, slam doors and stomp on the floor. He would also destroy his mothers possessions0 Including putting holes in the walls and breaking windows) but never his own. It was reported that the frequency of the tantrums were variable depending on how often he was told no. At this time the pts mother also reported that the pt hears voices, destroys property, urinated in inappropriate places, public cursing, inappropriate dressing, possible depression. At the time of the report the pts outcome was unknown. Upon internal review, pervasive developmental disorder and mental retardation were considered to be other important medical events (OMIC). Follow up information received on 9/12/06 reported the following adverse experienced recurrent otitis media and unspecified reaction to DTP. No further records are available upon request.